✦ LIBER ✦

Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer

✍ Scribed by Msaouel, Pavlos; Nandikolla, Gayathri; Pneumaticos, Spyros G; Koutsilieris, Michael

Book ID: 125547228
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 617 KB
Volume: 22
Category: Article
ISSN: 1354-3784
DOI: 10.1517/13543784.2013.824422

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beyond simple castration: targeting the

Beyond simple castration: targeting the molecular basis of treatment resistance in advanced prostate cancer

✍ Martin Gleave; Hideaki Miyake; Kim Chi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 459 KB

Calcium metabolism in castration-resista

Calcium metabolism in castration-resistant prostate cancer patients: Development of a quantitative urinary assay for extent of bone metastasis

✍ D.J. Hillegonds*; C.-X. Pan; P.N. Lara Jr. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

MP49-15 DOES TUMOR MICROENVIRONMENT AFFE

MP49-15 DOES TUMOR MICROENVIRONMENT AFFECT THE RESPONSE OF CASTRATION RESISTANT PROSTATE CANCER TO THERAPY IN BONE VS VISCERAL METASTASES?

✍ Haider, Maahum; Coleman, Ilsa; Zhang, Xiaotun; Brown, Lisha; Kollath, Lori; Kooc 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 57 KB

113 - A pathogenetic role for prostate-s

113 - A pathogenetic role for prostate-specific antigen (PSA) in osteoblastic bone metastasis: Implications for drug treatment of hormone-resistant disease

✍ A. Doherty; G. Smith; L. Banks; T.J. Christmas; R.J. Epstein 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 242 KB

755: A gemcitabine prodrug for the treat

755: A gemcitabine prodrug for the treatment of castration-resistant prostate cancer: Reduced metabolic inactivation combined with targeted drug delivery

✍ Karampelas, T.; Argyros, O.; Sayyad, N.; Tzakos, A.G.; Fokas, D.; Tamvakopoulos, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Denosumab versus zoledronic acid for tre

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

✍ Karim Fizazi; Michael Carducci; Matthew Smith; Ronaldo Damião; Janet Brown; Lawr 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 840 KB